BioSenic S.A. (0R55.L) LSE
0.00
-0.0002(-9.09%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.5M |
| Enterprise Value | 5.24M |
| P/E Ratio | 0.06 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.67 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | 6.13 |
| Return On Equity | -1.64 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -1.32M |
| Net Income | 20.93M |
| Diluted EPS | 0.03 |
Balance Sheet
| Total Cash | 69,000 |
| Total Cash/Share | 0 |
| Total Debt | 3.81M |
| Total Debt/Equity | -1.95 |
| Current Ratio | 0.55 |
| Book Value Per Share | -0 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 0.19 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.04 |
| Moving Average 200 Days | 0.06 |
Statistics
| Average Volume | 12,067 |
| Shares Outstanding | 652.86M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
